
ASPIRE-Med: A mental health medicines training program
Project Details
Funding partner
Australian Government Department of Health and Aged Care
Timeframe
2025-2028
Publications
Bellon, M., Cahalan, T., Deb, S., et al. (2026). The Australian psychotropic medicines training program for disability support workers: A study protocol in Easy Read. Advances in Neurodevelopmental Disorders, 10, 522-548. https://doi.org/10.1007/s41252-026-00483-3
Barratt, M., Speer, K., Deb, S., Bellon, M., Cahalan, T., et al. (2026). ASPIRE-Med project: A study protocol on an Australian psychotropic medicines training programme for disability support workers. BMJ Open, 16, Article e114351. https://doi.org/10.1136/bmjopen-2025-114351
Resources
Visit the project website here:
https://www.canberra.edu.au/faculties/health/carat/aspiremed
Team
DCI researchers
Research partners
University of Canberra- Dr Macey Barratt (lead), Associate Professor Mary Bushell
Monash Health- Associate Professor Andrea Simpson
University College London- Professor Shoumitro Deb
UNSW and National Centre of Excellence in Intellectual Disability Health- Associate Professor Rebecca Koncz
Summary
The Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability 2023 reported evidence suggesting psychotropic medicines were over-prescribed to people with intellectual and neurodevelopmental disabilities. This 4-year project is co-designing, developing and evaluating a national training program for disability support workers (DSWs) to strengthen knowledge, skills and confidence in supporting adults with intellectual and developmental disabilities who are prescribed psychotropic medicines. Using a participatory, stakeholder-led approach, the program will be informed by evidence reviews, learning needs analyses, focus groups, co-design activities, field testing and a large-scale feasibility trial to ensure the training is practical, accessible and relevant to real-world practice.
Impact
The project will build the capability of the disability workforce to support safe and appropriate psychotropic medicine use, promote non-pharmacological approaches to behaviours of concern, strengthen communication and supported decision-making, and enhance advocacy for regular medication review. Ultimately, this has the potential to reduce inappropriate psychotropic prescribing for behaviours of concern, improve health and quality-of-life outcomes for people with intellectual and developmental disabilities, and support person-centred, rights-based care across Australia.
